Previous 10 |
The fund has managed to recover most of its losses after the COVID-19 pandemic related global market sell-off earlier this year. High-Dividend stocks might become an interesting asset class, once investors shift away their focus from stay-at-home economy. VYM has been successful s...
John Paulson’s 13F portfolio value increased from $3.13B to $3.21B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and SPDR Gold ETF. The stake in Endo International plc was increased substantially during the quarter. ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...